Third, the PRDM1α protein was Talazoparib order Markedly diminished by the exogenous overexpression of miR-223 in YT cells and restored by miR-223 reduction Lonafarnib mouse in NKL and K562 cells, while PRDM1α mRNA was not affected. Thus, the post-transcriptional silencing of PRDM1 by miR-223 might well explain the discrepancy between high PRDM1 mRNA and low protein levels in EN-NK/T-NT

found in both our study and in previous reports [3, 11, 13]; and the targeting of PRDM1 by miR-223 might be an important mechanism of PRDM1 gene inactivation. However, we also noted that the restoration of PRDM1α protein did not occur in NK92 cells; low levels of both PRDM1 transcript and protein were detected in 6 EN-NK/T-NT tissues and NK92 cells, and the methylation in the CpG island

of PRDM1 gene reportedly occurs in NK92 cells [11]. Thus, it seems that PRDM1 may be regulated by other parallel regulatory pathways see more in addition to miR-223. The identification of miRNAs is a rapidly evolving field, and miRNAs are emerging as central players in the regulation of epigenetic expression [30–32]. The dysregulation of miRNAs has been linked to various types of cancer including lymphocytic malignancy [30, 32, 33]. miR-223 is located on chromosome Xq12 and plays an essential role in promoting granulocytic differentiation. It is associated with the suppression of erythrocytic differentiation [34–36]. A recent study demonstrated that the overexpression of miR-223 significantly downregulates the mRNA levels of the tumour suppressor gene FBXW7, resulting in an increase in the levels and activity of endogenous cycling E protein and genomic instability [37]. Moreover, higher expression levels of miR-223 aminophylline correlate with extranodal marginal-zone lymphoma of mucosa-associated lymphoid tissue of the stomach [38]. Markedly increased expression of miR-223 has also been observed in some T-cell acute lymphoblastic leukaemia cases with poor clinical outcomes [39]. Therefore, the function of miR-223 appears to differ in distinct tissues, and these functions may be ascribed to the complexity

of the interaction between a miRNA and its target genes and cell type-specific biological effects. Through ISH, we observed specific overexpression of miR-223 in EN-NK/T-NT FFPE samples compared with peripheral T-cell lymphoma and inflammatory nasal mucosa samples. Furthermore, miR-223 directly downregulated expression of the tumour suppressor gene PRDM1, indicating its potential importance in an epigenetic or post-transcriptional role in EN-NK/T-NT. The mechanism responsible for aberrant overexpression of miR-223 in EN-NK/T-NT is unclear. Although the overexpression of miRNAs in B-cell lymphoma is due to genomic amplification [40], no genomic amplifications or translocations of the Xq12 locus have been reported in several genome-wide analyses of NK/T-cell lymphomas [3, 8, 11].